CJC-1295 / Ipamorelin
This IPS-listed option is reviewed privately during consultation. Details are reviewed privately during consultation.
Back to peptide library
Growth hormone support
CJC-1295 / Ipamorelin
A clinician-guided peptide combination used in performance and longevity programs to support natural growth-hormone signaling, recovery, body composition, sleep quality, and healthy-aging goals.
CJC GHRH pathway Ipa GH secretagogue Clinical review required Labs guide monitoring
Overview
What is CJC-1295 / Ipamorelin?
CJC-1295 and Ipamorelin are commonly discussed together because they support growth-hormone release through complementary signaling pathways. CJC-1295 is related to growth hormone-releasing hormone activity, while Ipamorelin is a selective growth-hormone secretagogue.
IPS evaluates this option in the context of recovery, training demand, sleep, body composition, metabolic health, age, symptoms, and lab markers. It is not a replacement for individualized medical evaluation.
Common program goals
- Support recovery between training sessions
- Improve sleep and restorative routines
- Support lean-mass and body-composition goals
- Discuss healthy-aging and vitality support
- Monitor response with follow-up and labs when appropriate
IPS access
Available CJC / Ipamorelin listing.
This entry comes from the IPS access available list. Final route and candidacy depend on consultation, availability, and clinician judgment.
Typical evaluation
Goals, sleep, training volume, medical history, medications, glucose markers, hormone context, and IGF-1 or related labs may be reviewed.
Recovery and longevity
Often discussed when recovery, sleep, body composition, and healthy-aging goals overlap.
Mechanism
How the combination may support GH signaling.
CJC-1295 / Ipamorelin is commonly framed as a dual-pathway growth-hormone support strategy. The goal is to encourage the body's own signaling rather than directly replacing growth hormone.
GHRH pathway
CJC-1295 is discussed for its relationship to growth hormone-releasing hormone signaling and pituitary GH release.
Secretagogue support
Ipamorelin is discussed as a selective GH secretagogue that may complement CJC-style signaling.
IGF-1 context
Growth-hormone signaling can affect IGF-1 pathways, which is why lab context and monitoring may matter.
Behavior foundation
IPS pairs peptide discussions with sleep, protein, training load, resistance work, hydration, and recovery planning.
Process
How CJC / Ipamorelin care works at IPS.
Consultation
Review goals, recovery, sleep, training demand, medical history, medications, and peptide experience.
Baseline Review
Labs may be reviewed to understand hormone, metabolic, and safety context before protocol design.
Protocol Design
If appropriate, your clinician reviews instructions, timing, expectations, and follow-up cadence.
Ongoing Support
Follow-up helps evaluate sleep, recovery, body composition, tolerance, and whether the plan should change.
Safety & candidacy
Growth-hormone support requires clinical context.
CJC-1295 / Ipamorelin is not appropriate for everyone. IPS reviews health history, relevant labs, cancer history, glucose concerns, medications, pregnancy-related factors where applicable, and individual risk before discussing treatment.
Common effectsInjection-site irritation, flushing, water retention, headache, or appetite/sleep changes may occur.
ScreeningGrowth-hormone signaling should be discussed carefully in patients with certain cancer histories, uncontrolled metabolic disease, or complex endocrine issues.
MonitoringFollow-up may include symptom review, response tracking, and lab monitoring when clinically useful.
No guaranteesResults vary and depend on sleep, training, nutrition, tolerance, and individual response.
Questions
Frequently asked.
Is this the same as taking growth hormone?
No. CJC-1295 / Ipamorelin is generally discussed as a secretagogue strategy that supports the body's own signaling rather than direct growth-hormone replacement.
What goals does IPS usually pair it with?
Recovery, sleep quality, body composition, training readiness, vitality, and healthy-aging goals are common reasons patients ask about it.
Will I need labs?
Labs may be recommended depending on your history, symptoms, goals, and clinician review. IGF-1 and metabolic markers may be relevant in some cases.
Can it be combined with other programs?
Sometimes, but combinations require clinician review so overlapping goals, risks, and monitoring needs are clear.
Contact
Ask IPS about CJC / Ipamorelin eligibility.
Complete the form and IPS will follow up about consultation scheduling and next steps.
Medical note This page is educational and is not intended to diagnose, treat, cure, or prevent disease. Peptide decisions require consultation with a qualified clinician.